Marni Tierno: Exciting data on identifying clonal hematopoiesis variants in solid tumor tissue

Marni Tierno, Director, Medical Affairs at Illumina, posted on LinkedIn:

“Thank you to our collaborators Karina Eterovic, Eurofins Viracor BioPharma Services for presenting exciting data on identifying clonal hematopoiesis variants in solid tumor tissue and plasma specimens during ASCO2024! If you did not get the chance to see this data, check it out online Abstract 3051. If you think you know how to guess which variants are clonal hematopoiesis versus tumor-derived, you may be surprised by our conclusions.”

Source: Marni Tierno/LinkedIn